What is Qulipta and What is it Used For?

Qulipta (atogepant) is an oral prescription medication approved by the FDA for the preventive treatment of migraine in adults. It belongs to a class of drugs called CGRP receptor antagonists, which work by blocking calcitonin gene-related peptide (CGRP) receptors in the brain that are involved in migraine pathways.

Qulipta is specifically indicated for migraine prevention, meaning it is taken daily to reduce the frequency of migraine attacks rather than treating migraines after they occur. Clinical studies have demonstrated that Qulipta can help reduce the number of migraine days per month when taken as prescribed by a healthcare provider.

The medication is available in tablet form and is typically taken once daily. Qulipta offers patients and healthcare providers an oral option for migraine prevention, which may be preferred by some patients over injectable alternatives. As with all prescription medications, Qulipta should only be used under the guidance of a qualified healthcare professional.

Patients considering Qulipta should discuss their complete medical history with their healthcare provider, including any other medications they are taking. Healthcare providers can determine if Qulipta is appropriate based on individual patient factors, migraine frequency, and treatment goals.